Product NDC: | 65862-554 |
Proprietary Name: | Minocycline Hydrochloride |
Non Proprietary Name: | Minocycline Hydrochloride |
Active Ingredient(s): | 45 mg/1 & nbsp; Minocycline Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-554 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202261 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121119 |
Package NDC: | 65862-554-30 |
Package Description: | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-554-30) |
NDC Code | 65862-554-30 |
Proprietary Name | Minocycline Hydrochloride |
Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-554-30) |
Product NDC | 65862-554 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Minocycline Hydrochloride |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20121119 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | MINOCYCLINE HYDROCHLORIDE |
Strength Number | 45 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Tetracycline-class Drug [EPC],Tetracyclines [Chemical/Ingredient] |